Form 4 Tracker
Arcutis Biotherapeutics, Inc.
ARQT

21 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 14, 2024Nov 14 9:59 PMBurnett Patrick
Proposed Sale
69,126$10.29$711.6K

View →

Nov 11, 2024Nov 12 4:34 PMCurran Terrie
Proposed Sale
8,687$10.85$94.2K

View →

Nov 4, 2024Nov 4 9:41 PMWatanabe Todd Franklin
Proposed Sale
13,871$8.68$120.5K

View →

Nov 4, 2024Nov 4 9:39 PMMatsuda Masaru
Proposed Sale
5,015$8.68$43.6K

View →

Nov 4, 2024Nov 4 9:37 PMBurnett Patrick
Proposed Sale
15,441$8.68$134.1K

View →

Nov 1, 2024Nov 1 6:51 PMWelgus Howard G.
Proposed Sale
10,000$8.65$86.5K

View →

Oct 2, 2024Oct 2 8:31 PMEdwards Larry Todd
Proposed Sale
3,725$10.01$37.3K

View →

Oct 1, 2024Oct 1 7:32 PMWelgus Howard G.
Proposed Sale
10,000$9.26$92.6K

View →

Sep 24, 2024Sep 24 7:51 PMTopper David Joseph
Proposed Sale
11,626$9.48$110.3K

View →

Sep 3, 2024Sep 3 5:37 PMWelgus Howard G.
Proposed Sale
10,000$10.77$107.7K

View →

← Previous

Page 7 of 7

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 4 9:17 PMKeith R LeonardDirector
Option Exercise
39,272$8.630(D)

View →

Feb 27, 2026Mar 4 1:43 AMLarry Todd EdwardsReporting Person's title: EVP, Chief Commercial Officer
Grant/Award
77,000$26.9777,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMTodd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer
Grant/Award
266,000$26.97266,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMMasaru MatsudaReporting Person's title: EVP, Chief Legal Officer
Grant/Award
97,000$26.9797,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMLatha VairavanSVP Chief Financial Officer
Grant/Award
70,000$26.9770,000(D)

View →

Feb 27, 2026Mar 4 1:41 AMPatrick BurnettReporting Person's title: EVP, Chief Medical Officer
Grant/Award
77,000$26.9777,000(D)

View →